RECOVER I Data After Post-Cardiotomy Cardiogenic Shock1
survival at 1 month
survival at 6 months
survival at 1 year
Hemodynamic parameters improved immediately after Impella 5.0® placement, leading to an increase in mean cardiac index (CI) from 1.4 to 2.5 L/min/m2 and an increase in MAP from 71 mmHg to 83 mmHg.
Surgical Best Practices and Algorithms for Cardiogenic Shock
Cardiothoracic Surgeon Mark Anderson, MD, discusses improvements in outcomes for patients in cardiogenic shock through the early use of mechanical circulatory support and the development of shock protocols with a heart team. Dr. Anderson also shares his experience treating patients who need escalation of support.
Ongoing and Upcoming Clinical Trials
National Cardiogenic Shock Initiative (NCSI) Study
This study seeks to improve mortality in patients with AMI cardiogenic shock (AMICS) using the NCSI Study algorithm.
STEMI Door-to-Unloading (DTU) Pivotal Randomized Controlled Trial
This trial is randomizing patients undergoing treatment for ST-Elevation Myocardial Infarction (STEMI) who are not in cardiogenic shock to either 30 minutes of unloading with Impella CP® prior to reperfusion or standard of care with immediate PCI.
- Griffith, B.P., et al. (2013). J Thorac Cardiovasc Surg, 145(2), 548-554.